Egaten

triclabendazole

Tablet (oral) · NDA 208711

Last listed protection ended

February 13, 2026

The FDA listed 1 exclusivity for Egaten, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities